Geode Capital Management’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $546K | Buy |
|
|||||
|
2025
Q1 | $676K | Buy |
|
|||||
|
2024
Q4 | $758K | Sell |
|
|||||
|
2024
Q3 | $778K | Sell |
|
|||||
|
2024
Q2 | $1.01M | Buy |
|
|||||
|
2024
Q1 | $1.48M | Buy |
|
|||||
|
2023
Q4 | $1.41M | Buy |
|
|||||
|
2023
Q3 | $384K | Buy |
|
|||||
|
2023
Q2 | $107K | Sell |
|
|||||
|
2023
Q1 | $430K | Buy |
|
|||||
|
2022
Q4 | $337K | Sell |
|
|||||
|
2022
Q3 | $514K | Buy |
|
|||||
|
2022
Q2 | $2.97M | Buy |
|
|||||
|
2022
Q1 | $4M | Buy |
|
|||||
|
2021
Q4 | $5.99M | Sell |
|
|||||
|
2021
Q3 | $8.44M | Buy |
|
|||||
|
2021
Q2 | $9.49M | Buy |
|
|||||
|
2021
Q1 | $2.21M | Buy |
|
|||||
|
2020
Q4 | $558K | Buy |
|
|||||
|
2020
Q3 | $175K | Hold |
|
|||||
|
2020
Q2 | $132K | Hold |
|
|||||
|
2020
Q1 | $110K | Buy |
|
|||||
|
2019
Q4 | $172K | Buy |
|
|||||
|
2019
Q3 | $180K | Hold |
|
|||||
|
2019
Q2 | $122K | Buy |
|
|||||
|
2019
Q1 | $197K | Hold |
|
|||||
|
2018
Q4 | $231K | Buy |
|
|||||
|
2018
Q3 | $198K | Hold |
|
|||||
|
2018
Q2 | $187K | Buy |
|
|||||
|
2018
Q1 | $27K | Hold |
|
|||||
|
2017
Q4 | $33K | Hold |
|
|||||
|
2017
Q3 | $48K | Hold |
|
|||||
|
2017
Q2 | $56K | Hold |
|
|||||
|
2017
Q1 | $58K | Hold |
|
|||||
|
2016
Q4 | $112K | Hold |
|
|||||
|
2016
Q3 | $125K | Buy |
|